ELIZABETH E REED

CIK 1283303 · Chief Legal Officer and GC · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.91M

Companies

4

Total Filings

82

Lifetime Open-Market Net

-$6.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVTX Chief Legal Officer and GC 105,211 $65.71 $6.91M -$6.42M 32 2026-05-06
Travere Therapeutics, Inc. (RTRX) Delisted SVP, GC & Corporate Secretary 25,431 -$510.1K 19 2020-11-17
Eiger BioPharmaceuticals, Inc. (CLDN) Delisted VP, General Counsel 11 $0 1 2015-01-05
ANADYS PHARMACEUTICALS INC (ANDS) Delisted SVP, Legal Affairs and GC $0 7 2011-01-24

Recent Filings · Page 9 of 9

82 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2007-12-11 ANADYS PHARMACEUTICALS INC (ANDS) Delisted Grant (A) $0 EDGAR
2007-09-10 ANADYS PHARMACEUTICALS INC (ANDS) Delisted Grant (A) $0 EDGAR
Showing 8182 of 82
Page 9 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.